A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma Journal Article
| Authors: | Hormigo, A.; Ding, B. S.; Rafii, S. |
| Article Title: | A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma |
| Keywords: | cancer survival; protein expression; unclassified drug; angiogenesis inhibitor; bevacizumab; note; drug targeting; temozolomide; cell proliferation; animals; mice; vasculotropin receptor; apoptosis; tumor markers, biological; vasculotropin receptor 2; autophosphorylation; cancer resistance; endothelium cell; endothelial cells; enzyme phosphorylation; vascular endothelium; glioblastoma; vasculotropin a; antiangiogenic therapy; tumor cell; cell transdifferentiation; angiogenesis inhibitors; tumor vascularization; vasculotropin receptor 1; angiopoietin 2; tumor necrosis; neuropilin 2; kalinin; basic fibroblast growth factor; laminin 5 gamma 2 |
| Journal Title: | Proceedings of the National Academy of Sciences of the United States of America |
| Volume: | 108 |
| Issue: | 11 |
| ISSN: | 0027-8424 |
| Publisher: | National Academy of Sciences |
| Date Published: | 2011-03-15 |
| Start Page: | 4271 |
| End Page: | 4272 |
| Language: | English |
| DOI: | 10.1073/pnas.1019656108 |
| PUBMED: | 21383166 |
| PROVIDER: | scopus |
| PMCID: | PMC3060236 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 23 June 2011" - "CODEN: PNASA" - "Source: Scopus" |
